Weighted Average Number of Shares Outstanding, Basic of SELLAS Life Sciences Group, Inc. from 30 Jun 2012 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
SELLAS Life Sciences Group, Inc. quarterly and annual Weighted Average Number of Shares Outstanding, Basic in shares history and change rate from 30 Jun 2012 to 30 Sep 2025.
  • SELLAS Life Sciences Group, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending 30 Sep 2025 was 108,396,260, a 59% increase year-over-year.
  • SELLAS Life Sciences Group, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 61,202,412, a 120% increase from 2023.
  • SELLAS Life Sciences Group, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 27,777,111, a 43% increase from 2022.
  • SELLAS Life Sciences Group, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 19,395,709, a 25% increase from 2021.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

SELLAS Life Sciences Group, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 108,396,260 +40,142,239 +59% 01 Jul 2025 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 98,558,567 +40,928,061 +71% 01 Apr 2025 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 87,760,320 +42,947,324 +96% 01 Jan 2025 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 61,202,412 +33,425,301 +120% 01 Oct 2024 31 Dec 2024 10-K 20 Mar 2025 2024 FY
Q3 2024 68,254,021 +39,898,594 +141% 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2025 2025 Q3
Q2 2024 57,630,506 +29,282,586 +103% 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2025 2025 Q2
Q1 2024 44,812,996 +21,265,434 +90% 01 Jan 2024 31 Mar 2024 10-Q 13 May 2025 2025 Q1
Q4 2023 27,777,111 +8,381,402 +43% 01 Oct 2023 31 Dec 2023 10-K 20 Mar 2025 2024 FY
Q3 2023 28,355,427 +7,793,076 +38% 01 Jul 2023 30 Sep 2023 10-Q 13 Nov 2024 2024 Q3
Q2 2023 28,347,920 +8,061,296 +40% 01 Apr 2023 30 Jun 2023 10-Q 13 Aug 2024 2024 Q2
Q1 2023 23,547,562 +7,650,083 +48% 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024 2024 Q1
Q4 2022 19,395,709 +3,914,596 +25% 01 Oct 2022 31 Dec 2022 10-K 28 Mar 2024 2023 FY
Q3 2022 20,562,351 +4,688,275 +30% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023 2023 Q3
Q2 2022 20,286,624 +5,016,336 +33% 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023 2023 Q2
Q1 2022 15,897,479 +1,020,162 +6.9% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q4 2021 15,481,113 01 Oct 2021 31 Dec 2021 10-K 16 Mar 2023 2022 FY
Q3 2021 15,874,076 +7,456,038 +89% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022 2022 Q3
Q2 2021 15,270,288 +8,552,388 +127% 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2022 2022 Q2
Q1 2021 14,877,317 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022 2022 Q1
Q3 2020 8,418,038 01 Jul 2020 30 Sep 2020 10-Q 12 Nov 2021 2021 Q3
Q2 2020 6,717,900 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021 2021 Q2
Q3 2017 39,250,419 +28,785,255 +275% 01 Jul 2017 30 Sep 2017 10-Q 09 Nov 2017 2017 Q3
Q2 2017 37,421,273 +28,319,543 +311% 01 Apr 2017 30 Jun 2017 10-Q 14 Aug 2017 2017 Q2
Q1 2017 26,406,356 +17,437,740 +194% 01 Jan 2017 31 Mar 2017 10-Q 10 May 2017 2017 Q1
Q3 2016 10,465,164 -151,392,358 -94% 01 Jul 2016 30 Sep 2016 10-Q 09 Nov 2017 2017 Q3
Q2 2016 9,101,730 -152,281,668 -94% 01 Apr 2016 30 Jun 2016 10-Q 14 Aug 2017 2017 Q2
Q1 2016 8,968,616 01 Jan 2016 31 Mar 2016 10-Q 10 May 2017 2017 Q1
Q3 2015 161,857,522 01 Jul 2015 30 Sep 2015 10-Q 09 Nov 2016 2016 Q3
Q2 2015 161,383,398 01 Apr 2015 30 Jun 2015 10-Q 09 Aug 2016 2016 Q2
Q2 2013 83,656,184 +18,544,037 +28% 01 Apr 2013 30 Jun 2013 10-Q 09 Aug 2013 2013 Q2
Q2 2012 65,112,147 01 Apr 2012 30 Jun 2012 10-Q 09 Aug 2013 2013 Q2

SELLAS Life Sciences Group, Inc. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 61,202,412 +33,425,301 +120% 01 Jan 2024 31 Dec 2024 10-K 20 Mar 2025 2024 FY
2023 27,777,111 +8,381,402 +43% 01 Jan 2023 31 Dec 2023 10-K 20 Mar 2025 2024 FY
2022 19,395,709 +3,914,596 +25% 01 Jan 2022 31 Dec 2022 10-K 28 Mar 2024 2023 FY
2021 15,481,113 +7,504,009 +94% 01 Jan 2021 31 Dec 2021 10-K 16 Mar 2023 2022 FY
2020 7,977,104 01 Jan 2020 31 Dec 2020 10-K 31 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.